John W. Loewy
Impact in
- Hematology top 2%
- Platelet Disorders and Treatments
- Oncology top 5%
- Neutropenia and Cancer Infections
Papers in
- Oncology 9
- Neutropenia and Cancer Infections 4
-
- PI3K/AKT/mTOR signaling in cancer 5
- Co-authors
- Elliot Ehrich (3 shared papers)Bernard L. Silverman (2 shared papers)David R. Gastfriend (1 shared paper)Henry R. Kranzler (1 shared paper)James C. Garbutt (1 shared paper)Stephanie S. O’Malley (1 shared paper)Helen M. Pettinati (1 shared paper)James A. Kaye (4 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Therapeutic Innovation & Regulatory Science (3 papers)Annals of Oncology (2 papers)JAMA (1 paper)Cancer (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
John W. Loewy
38 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 119
- Hematology 372
- Oncology 703
- Clinical Biochemistry 124
- Epidemiology 547
- Pathology and Forensic Medicine 281
Countries citing papers authored by John W. Loewy
This map shows the geographic impact of John W. Loewy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Loewy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Loewy more than expected).
Fields of papers citing papers by John W. Loewy
This network shows the impact of papers produced by John W. Loewy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Loewy. The network helps show where John W. Loewy may publish in the future.
Co-authors
The 25 scholars most cited alongside John W. Loewy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 461 | |
| 2 | A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. | 1996 | 219 |
| 3 | 1993 | 215 | |
| 4 | 2011 | 195 | |
| 5 | 1996 | 163 | |
| 6 | 1999 | 146 | |
| 7 | 1997 | 104 | |
| 8 | 1999 | 88 | |
| 9 | 1996 | 83 | |
| 10 | 1994 | 75 | |
| 11 | 2009 | 71 | |
| 12 | 2011 | 67 | |
| 13 | 2004 | 62 | |
| 14 | 2007 | 53 | |
| 15 | 1993 | 38 | |
| 16 | 2012 | 30 | |
| 17 | 1998 | 30 | |
| 18 | 2012 | 29 | |
| 19 | 1990 | 28 | |
| 20 | 2016 | 27 |
About John W. Loewy
John W. Loewy is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hematology and Pathology and Forensic Medicine, having authored 39 papers that have together received 2.3k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Statistical Methods in Clinical Trials (5 papers), Cancer Research and Treatments (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Neutropenia and Cancer Infections (4 papers), Virus-based gene therapy research (3 papers), Cancer Genomics and Diagnostics (3 papers) and Meta-analysis and systematic reviews (3 papers). The work is most often cited by research in Hematology (372 citations), Oncology (703 citations), Clinical Biochemistry (124 citations), Epidemiology (547 citations) and Pathology and Forensic Medicine (281 citations). John W. Loewy has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Elliot Ehrich, Bernard L. Silverman, David R. Gastfriend, Henry R. Kranzler, James C. Garbutt, Stephanie S. O’Malley, Helen M. Pettinati, James A. Kaye, Rani Kanthan and K. Beach. Their work appears in journals such as Journal of Clinical Oncology, Therapeutic Innovation & Regulatory Science, Annals of Oncology, JAMA and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.